Akebia Therapeutics to Report Second Quarter 2021 Financial Results and Discuss Recent Business Highlights
Akebia Therapeutics, Inc. (Nasdaq: AKBA) has announced that it will release its financial results for the second quarter ended June 30, 2021, on August 5, 2021, before markets open. The company will also host a conference call at 9:00 a.m. ET on the same day to discuss the results and recent business developments. Interested parties can listen live by calling (877) 458-0977 domestically or (484) 653-6724 internationally. A replay will be available after the call until August 11, 2021.
- Upcoming financial results announcement may provide insights into company performance.
- Conference call scheduled to discuss recent business highlights.
- No specific financial metrics or performance data provided in the PR.
CAMBRIDGE, Mass., July 26, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced plans to release its financial results for the second quarter ended June 30, 2021, on Thursday, August 5, 2021 before the opening of the financial markets.
Akebia will host a conference call at 9:00 a.m. Eastern Time on Thursday, August 5, to discuss its second quarter financial results and recent business highlights. To listen to the conference call, please dial (877) 458-0977 (domestic) or (484) 653-6724 (international) using conference ID number 5529396. The call will also be webcast LIVE and can be accessed via the Investors section of the Company's website at http://ir.akebia.com.
A replay of the conference call will be available two hours after the completion of the call through August 11, 2021. To access the replay, dial (855) 859-2056 (domestic) or (404) 537-3406 (international) and reference conference ID number 5529396. An online archive of the conference call can be accessed via the Investors section of the Company's website at http://ir.akebia.com.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. The Company was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at https://akebia.com/ which does not form a part of this release.
Investor Contact
Kristen K. Sheppard, Esq.
ir@akebia.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-report-second-quarter-2021-financial-results-and-discuss-recent-business-highlights-301340605.html
SOURCE Akebia Therapeutics
FAQ
When will Akebia Therapeutics release its second quarter 2021 financial results?
What time is the Akebia Therapeutics conference call for Q2 2021 results?
How can I listen to Akebia's conference call?
Will there be a replay of the conference call?
